Artwork
iconShare
 
Manage episode 514648285 series 2844701
Content provided by Dr Greg Dennis. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr Greg Dennis or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Send us a text

Today, I’m joined by Dr. William LaValley — one of the world’s leading researchers and medical doctors in the field of integrative cancer treatment.

Dr. LaValley has spent decades combining the latest discoveries in molecular biology with evidence-based, integrative therapies for cancer. He draws upon the vast database of research available through PubMed to identify the anti-cancer potential of natural compounds and repurposed, or off-label, pharmaceutical drugs.

Since earning his M.D. in 1986, Dr. LaValley has developed sophisticated, evidence-driven databases mapping the molecular pathways of cancer. These insights have allowed him to design personalized treatment protocols that complement — rather than replace — conventional chemotherapy and radiation therapy.

In this episode, we’ll discuss how understanding molecular biology helps identify new targets for treatment, how repurposed drugs can work synergistically with standard therapies, and what the future of integrative oncology looks like.

You can find him at:

www.Lavalleymdprotocols.com

#IntegrativeOncology #CancerResearch #MolecularMedicine #RepurposedDrugs #FunctionalMedicine #CancerTreatment #FitRxPodcast

  continue reading

168 episodes